FOXK2 and central nervous system cancer: Similar conclusions have been derived from FOXK2 knockdown studies, where loss of FOXK2 promotes growth, invasion and migration in glioma cells, followed by modulation of expression of E-cadherin, N-cadherin and vimentin EMT markers [47].